NZ519330A - New sequences for altering mammalian ovarian function and ovulation rate - Google Patents

New sequences for altering mammalian ovarian function and ovulation rate

Info

Publication number
NZ519330A
NZ519330A NZ51933002A NZ51933002A NZ519330A NZ 519330 A NZ519330 A NZ 519330A NZ 51933002 A NZ51933002 A NZ 51933002A NZ 51933002 A NZ51933002 A NZ 51933002A NZ 519330 A NZ519330 A NZ 519330A
Authority
NZ
New Zealand
Prior art keywords
new sequences
ovarian function
ovulation rate
mammalian ovarian
altering
Prior art date
Application number
NZ51933002A
Other languages
English (en)
Inventor
George Henry Davis
Susan May Galloway
Scott Michael Gregan
James Patrick Hanrahan
Jennifer Lee Juengal
Kenneth Pattrick Mcnatty
Philippe Mulsant
Richard Patrick Powell
Original Assignee
George Henry Davis
Susan May Galloway
Scott Michael Gregan
James Patrick Hanrahan
Jennifer Lee Juengel
Kenneth Pattrick Mcnatty
Philippe Mulsant
Richard Patrick Powell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by George Henry Davis, Susan May Galloway, Scott Michael Gregan, James Patrick Hanrahan, Jennifer Lee Juengel, Kenneth Pattrick Mcnatty, Philippe Mulsant, Richard Patrick Powell filed Critical George Henry Davis
Priority to NZ51933002A priority Critical patent/NZ519330A/xx
Priority to CA002490051A priority patent/CA2490051A1/fr
Priority to JP2004510436A priority patent/JP2006510345A/ja
Priority to PCT/NZ2003/000109 priority patent/WO2003102199A1/fr
Priority to AU2003235525A priority patent/AU2003235525B2/en
Priority to EP03723538A priority patent/EP1551973A4/fr
Priority to BR0311465-1A priority patent/BR0311465A/pt
Publication of NZ519330A publication Critical patent/NZ519330A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Environmental Sciences (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ51933002A 2002-05-30 2002-05-30 New sequences for altering mammalian ovarian function and ovulation rate NZ519330A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
NZ51933002A NZ519330A (en) 2002-05-30 2002-05-30 New sequences for altering mammalian ovarian function and ovulation rate
CA002490051A CA2490051A1 (fr) 2002-05-30 2003-05-30 Nouvelles sequences gdf-9 et gdf-9b (bmp-15) destinees a modifier la fonction ovarienne et la vitesse d'ovulation chez des mammiferes
JP2004510436A JP2006510345A (ja) 2002-05-30 2003-05-30 哺乳動物の排卵機能および排卵頻度を改変する新しいｇｄｆ−９およびｇｄｆ−９ｂ（ｂｍｐ−１５）配列
PCT/NZ2003/000109 WO2003102199A1 (fr) 2002-05-30 2003-05-30 Nouvelles sequences gdf-9 et gdf-9b (bmp-15) destinees a modifier la fonction ovarienne et la vitesse d'ovulation chez des mammiferes
AU2003235525A AU2003235525B2 (en) 2002-05-30 2003-05-30 New GDF-9 and GDF-9B (BMP-15) sequences for altering mammalian ovarian function and ovulation rate
EP03723538A EP1551973A4 (fr) 2002-05-30 2003-05-30 Nouvelles sequences gdf-9 et gdf-9b (bmp-15) destinees a modifier la fonction ovarienne et la vitesse d'ovulation chez des mammiferes
BR0311465-1A BR0311465A (pt) 2002-05-30 2003-05-30 Novas sequências gdf-9 e gdf-9b (bmp-15) para alteração da função ovariana e da taxa de ovulação de mamìferos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ51933002A NZ519330A (en) 2002-05-30 2002-05-30 New sequences for altering mammalian ovarian function and ovulation rate

Publications (1)

Publication Number Publication Date
NZ519330A true NZ519330A (en) 2004-12-24

Family

ID=29707820

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ51933002A NZ519330A (en) 2002-05-30 2002-05-30 New sequences for altering mammalian ovarian function and ovulation rate

Country Status (7)

Country Link
EP (1) EP1551973A4 (fr)
JP (1) JP2006510345A (fr)
AU (1) AU2003235525B2 (fr)
BR (1) BR0311465A (fr)
CA (1) CA2490051A1 (fr)
NZ (1) NZ519330A (fr)
WO (1) WO2003102199A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0518900A2 (pt) * 2004-12-02 2008-12-16 Agres Ltd modulaÇço de ovulaÇço
JP2008521891A (ja) * 2004-12-02 2008-06-26 アグリサーチ・リミテッド 排卵の調節
WO2006130022A1 (fr) * 2005-05-30 2006-12-07 Agresearch Limited Modulation de l'ovulation au moyen d'agonistes et d'antagonistes de bmprii
ATE487800T1 (de) * 2005-09-13 2010-11-15 Neocodex S L Verfahren zum in-vitro-nachweis einer veranlagung zur entwicklung von veränderungen der ovarienfunktion
ES2338960B1 (es) * 2007-11-23 2011-04-19 Carnes Oviaragon S.C.L. Procedimiento de mejora de la productividad en ganado ovino.
BRPI0706173C1 (pt) * 2007-11-23 2011-02-22 Brasil Pesquisa Agropec metodo para identificação massal de animais com aumento na prolificidade
WO2014018404A1 (fr) * 2012-07-21 2014-01-30 Baylor College Of Medicine Hétérodimères gdf9/bmp15 pour augmenter la fertilité
CN104774836A (zh) * 2015-04-15 2015-07-15 兰州大学 一种提高绵羊产羔数多基因聚合早期选种的方法
EP3577457A4 (fr) * 2017-02-01 2021-01-20 Robert Bruce Gilchrist Facteurs de croissance sécrétés par les gamètes
CN112601756A (zh) * 2018-05-09 2021-04-02 莫拿什大学 用于增强生育力的剂和方法
CN116649285A (zh) * 2023-05-12 2023-08-29 上海市老年医学中心 一种早发性卵巢功能不全小鼠模型的构建方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030617A (en) * 1993-01-12 2000-02-29 The Johns Hopkins University School Of Medicine Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation
EP1181041A2 (fr) * 1999-04-30 2002-02-27 Curis, Inc. Augmentation de fertilite induite par des morphogenes
NZ500844A (en) * 2000-05-05 2003-06-30 Agres Ltd Nucleotide sequences (mutated GDF-9B polypeptides) involved in increasing and decreasing mammalian ovulation rate
NZ502796A (en) * 2000-06-15 2003-02-28 Agres Ltd Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9

Also Published As

Publication number Publication date
WO2003102199A1 (fr) 2003-12-11
BR0311465A (pt) 2005-04-05
AU2003235525B2 (en) 2008-09-11
EP1551973A4 (fr) 2006-06-07
JP2006510345A (ja) 2006-03-30
EP1551973A1 (fr) 2005-07-13
CA2490051A1 (fr) 2003-12-11
AU2003235525A1 (en) 2003-12-19

Similar Documents

Publication Publication Date Title
AU2003222069A8 (en) Mammalian cdr mimetibodies, compositions, methods and uses
EP1545608A4 (fr) Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations
EP1572079A3 (fr) Corps mimetiques de cdr de mammifere, compositions, procedes et utilisations
GB2386176B (en) Refrigerator and method for operating the same
PL372902A1 (en) New use
IL158115A0 (en) Sapogenin derivatives, their synthesis and use, and methods based upon their use
AU2003239197A8 (en) Novel stable anti-cd22 antibodies
GB0301240D0 (en) Sliding material
NZ519330A (en) New sequences for altering mammalian ovarian function and ovulation rate
AU2003244141A1 (en) Hydrogen occluding material and method for use thereof
PL358287A1 (en) Tampering tip
AU2003239579A1 (en) Antisense modulation of vegf-c expression
AU2003263575A8 (en) Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate
GB0220658D0 (en) Immunotherapy
IL165522A0 (en) Controlled ovarian hyperstimulation
AU2003217942A8 (en) Modulators of leukocyte activation, compositions, and methods of use
EP1552828A4 (fr) Activateur du recepteur de la thrombopoietine et procede de production
AU2003225642A1 (en) Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs
GB0229445D0 (en) Process,composition and use
AU2003216893A1 (en) Phenethylacrylamide, methods for the production thereof and agents containing the same
AU2003257785A1 (en) Liquid activator
AU2003261227A8 (en) Modulators of b-lymphocyte activation, myosin-1f compositions and methods of use
PL374039A1 (en) Acutumine and acutumine compounds, synthesis and use
AU2003271816A8 (en) Benzoquinonemonoimine derivatives, synthesis method, dyeing compositions containing same and use thereof
AU2003232367A8 (en) Synthesis of the peptide cgggqrlgdqwavghlmnh2, labelling method

Legal Events

Date Code Title Description
PSEA Patent sealed
ASS Change of ownership

Owner name: RICHARD PATRICK POWELL, IE

Free format text: OLD OWNER(S): GEORGE HENRY DAVIS; SUSAN MAY GALLOWAY; SCOTT MICHAEL GREGAN; JAMES PATRICK HANRAHAN;JENNIFER LEE JUENGEL; KENNETH PATTRICK MCNATTY; PHILIPPE MULSANT; RICHARD PATRICK POWELL

Owner name: JAMES PATRICK HANRAHAN, IE

Free format text: OLD OWNER(S): GEORGE HENRY DAVIS; SUSAN MAY GALLOWAY; SCOTT MICHAEL GREGAN; JAMES PATRICK HANRAHAN;JENNIFER LEE JUENGEL; KENNETH PATTRICK MCNATTY; PHILIPPE MULSANT; RICHARD PATRICK POWELL

Owner name: PHILIPPE MULSANT, FR

Free format text: OLD OWNER(S): GEORGE HENRY DAVIS; SUSAN MAY GALLOWAY; SCOTT MICHAEL GREGAN; JAMES PATRICK HANRAHAN;JENNIFER LEE JUENGEL; KENNETH PATTRICK MCNATTY; PHILIPPE MULSANT; RICHARD PATRICK POWELL

Owner name: OVITA LIMITED, NZ

Free format text: OLD OWNER(S): GEORGE HENRY DAVIS; SUSAN MAY GALLOWAY; SCOTT MICHAEL GREGAN; JAMES PATRICK HANRAHAN;JENNIFER LEE JUENGEL; KENNETH PATTRICK MCNATTY; PHILIPPE MULSANT; RICHARD PATRICK POWELL

ASS Change of ownership

Owner name: JAMES PATRICK HANRAHAN, IE

Free format text: OLD OWNER(S): OVITA LIMITED; RICHARD PATRICK POWELL; PHILIPPE MULSANT; JAMES PATRICK HANRAHAN

Owner name: OVITA LIMITED, NZ

Free format text: OLD OWNER(S): OVITA LIMITED; RICHARD PATRICK POWELL; PHILIPPE MULSANT; JAMES PATRICK HANRAHAN

Owner name: NATIONAL UNIVERSITY OF IRELAND, IE

Free format text: OLD OWNER(S): OVITA LIMITED; RICHARD PATRICK POWELL; PHILIPPE MULSANT; JAMES PATRICK HANRAHAN

Owner name: PHILIPPE MULSANT, FR

Free format text: OLD OWNER(S): OVITA LIMITED; RICHARD PATRICK POWELL; PHILIPPE MULSANT; JAMES PATRICK HANRAHAN

ASS Change of ownership

Owner name: JAMES PATRICK HANRAHAN, IE

Free format text: OLD OWNER(S): NATIONAL UNIVERSITY OF IRELAND, GALWAY; OVITA LIMITED; JAMES PATRICK HANRAHAN; PHILIPPE MULSANT

Owner name: NATIONAL UNIVERSITY OF IRELAND, IE

Free format text: OLD OWNER(S): NATIONAL UNIVERSITY OF IRELAND, GALWAY; OVITA LIMITED; JAMES PATRICK HANRAHAN; PHILIPPE MULSANT

Owner name: AGRESEARCH LIMITED, NZ

Free format text: OLD OWNER(S): NATIONAL UNIVERSITY OF IRELAND, GALWAY; OVITA LIMITED; JAMES PATRICK HANRAHAN; PHILIPPE MULSANT

Owner name: PHILIPPE MULSANT, FR

Free format text: OLD OWNER(S): NATIONAL UNIVERSITY OF IRELAND, GALWAY; OVITA LIMITED; JAMES PATRICK HANRAHAN; PHILIPPE MULSANT

RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed
ERR Error or correction

Free format text: THE OWNER HAS BEEN CORRECTED TO 857141, AGRESEARCH LIMITED, 5TH FLOOR, TOWER BLOCK, RUAKURA RESEARCH CENTRE, HAMILTON, NZ; 942116, JAMES PATRICK HANRAHAN, C/- A J PARK, PO BOX 949, WELLINGTON 6140, NZ; 942119, PHILIPPE MULSANT, C/- A J PARK, PO BOX 949, WELLINGTON 6140, NZ; 1057080, NATIONAL UNIVERSITY OF IRELAND, GALWAY, C/- A J PARK, PO BOX 949, WELLINGTON 6140, NZ

Effective date: 20150821